Clinical trials
Completed Adrenoleukodystrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 4 |
| Pujol, Aurora, M.D. | 3 |
| Genetix Biotherapeutics Inc. | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Children's Hospital of Philadelphia | 1 |
| FDA Office of Orphan Products Development | 1 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 1 |
| Jakub Antczak | 1 |
| Leipzig University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adrenoleukodystrophy | 24 |
| Leukodystrophy, Metachromatic | 7 |
| Leukodystrophy, Globoid Cell | 6 |
| Peroxisomal Disorders | 5 |
| Wolman Disease | 5 |
| Mucopolysaccharidosis I | 4 |
| Anemia, Diamond-Blackfan | 3 |
| Fucosidosis | 3 |
| Gangliosidosis, GM1 | 3 |
| Gaucher Disease | 3 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.